Genomenon Partners with Pharming to Advance APDS Diagnosis
May 2, 2024
Genomenon Making Variant Data on the PIK3CD and PIK3R1 Genes Available to Genetic Testing Labs Across the World Genomenon, a genomic intelligence company, has partnered with Pharming Group in an effort to make variant data on the PIK3CD and PIK3R1 genes available to genetic testing labs, as well as clinicians and researchers, worldwide. This data [...]
$27 million to map 50 million human cellsand uncover genetic fingerprints of disease
May 1, 2024
With researchers, The Hon. David Harris MP, NSW Minister for Medical Research, and Madeleine Jandura who was diagnosed with ulcerative colitis at age 11. Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research’s TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, [...]
May 1, 2024
Powered by pioneering technology licensed from Johns Hopkins University, the NOMADX platform aims to enable anyone to perform the rapid and accurate identification of harmful bacteria and viruses in food, water, air, and clinical applications with sensitivity equivalent to PCR NEW YORK -- NOMADX Holdings LLC ("NOMADX Holdings"), a private company pioneering new technologies for [...]
Exum Instruments and Edge Scientific Announce Strategic Partnership
May 1, 2024
Providing researchers and facilities with state-of-the-art innovations in mass spectrometry DENVER, CO – Exum Instruments, manufacturer of instruments and software ecosystems that increase the speed of development and discovery, is excited to announce a strategic partnership with Edge Scientific, a leading Canadian distributor of scientific instruments. This collaboration marks a significant milestone for Exum’s growth [...]
May 1, 2024
Bio-Rad's Range of StarBright Dyes Conjugated to Highly Validated Antibodies Now Totals 32 Dyes, Providing Greater Choice and Flexibility for Conventional and Full-Spectrum Flow Cytometry in Immunology Research. HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of three [...]
Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
May 1, 2024
Latest addition to the NovoCyte family celebrates a decade of flow cytometry excellence SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse [...]
Padraig McDonnell Assumes Agilent CEO Role
May 1, 2024
SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. [...]
Curio Bioscience Reports Clarifying Decision From European Unified Patent Court (UPC)
April 30, 2024
Court finds non-infringement by Curio Seeker with respect to over-reaching claim by 10x Genomics PALO ALTO, Calif. ---Curio Bioscience, a leading innovator of high-precision tools for the life sciences industry, today announced that a decision in a court case has been made. The European Unified Patent Court (UPC) today announced a finding that Curio Seeker [...]
Spheryx Welcomes Dr. Kevin Dahl as Director of Technical Operations & Sales
April 30, 2024
Dr. Kevin Dahl comes to Spheryx with a wealth of experience in analytical instrumentation to be our new Director of Technical Operations and Sales. New York, NY – Spheryx Inc. is pleased to announce that Kevin Dahl, PhD, will be joining Spheryx as Director of Technical Operations and Sales. Kevin joins Spheryx with deep experience [...]
April 30, 2024
Oxford, UK – OGT, a leading global provider of genomic research and diagnostic solutions, announces the launch of the RNA-based SureSeq™ Myeloid Fusion Panel, a new next-generation sequencing (NGS) tool for identifying key fusion genes implicated in acute myeloid leukaemia (AML). Intelligently designed in collaboration with leading myeloid cancer experts, the SureSeq Myeloid Fusion Panel [...]

